Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

NCT00844662 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Failure

Interventions

DRUG: Fermagate
DRUG: Sevelamer hydrochloride

Sponsor

Ineos Healthcare Limited